Claret Capital Partners Fund IV

United Kingdom
Growth
Share

About Claret Capital Partners Fund IV

Growth Debt and Venture Debt for Tech, Life Sciences, Climate Tech, SaaS, Digital Health

Investment Focus

Location / RegionUnited Kingdom
Funding StageGrowth
Industry Focus
Biotech
Climate Sustainability
Deep Tech
Digital Health
Saas

Investor Signals Profile

active

Sweet Spot

European growth-stage tech/life sciences founder needing debt

venture debt
tech-enabled businesses
European growth
life sciences
growth debt
medtech

Bullish Signals

Portfolio exit: Phoenix Technologies acquired by Lenovoexternal
Active deal flow, recent post activityexternal
Fund IV actively deploying, life sciences focuslinkedin
Shortlisted: Irish & HealthInvestor Awards 2026linkedin
Q1 2026 newsletter live — team growinglinkedin
New investments: ACT LAB & Cinclus Pharmalinkedin
£50k raised for Ukrainian Action charitylinkedin
H1 2026: 180% deployment growth YoY, 14 new facilitieslinkedin
€1.5bn deployed across 200+ European innovatorslinkedin
Team expanded to 32, France office reinforcedlinkedin
8 portfolio adds H1 2026: Cinclus, Inventiva, Surfelinkedin
Shortlisted Alternative Credit Investor Awards 2026linkedin
Recognition at Irish Investor Awards for Neurent Medicallinkedin
14 new facilities in H1 2026, strong momentumlinkedin
€30m medtech financing to Carvolix for commercialisationexternal

Contrarian Signals

No contrarian signals recorded.

Founder Do's

Build European tech/life sciences with strong unit economics
Target growth stage (post-PMF, pre-IPO)
Leverage Claret's 32-person on-ground team across Europe
Deploy debt for commercialisation acceleration & portfolio scaling

Founder Don'ts

Early stage pre-revenue; they fund growth debt
Non-EU/non-tech founders outside core thesis

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

Fund Overview

Fund Size€350M
Saves0

Key People

David Bateman, Johan Kampe

Related Funds

Empirical Ventures Fund I

£15M
United Kingdom
Pre Seed
Deep Tech, Energy Tech, Biotech, Med Tech, Therapeutics
Fund Manager:Dr Johnathan Matlock
Pre Seed
Deep Tech
Energy Tech
Biotech
Med Tech
Therapeutics

DIG Ventures Fund I

£100M
United Kingdom
Pre Seed
Ai Ml, Saas
Fund Manager:Ross Mason, Melissa Klinger, Scott Grimes
Pre Seed
Ai Ml
Saas

Emerge Fund II.

$56M
United Kingdom
Pre Seed
Ai Ml, Digital Education Consumer
Fund Manager:Nic Newmann
Pre Seed
Ai Ml
Digital Education Consumer